Aplastic anaemia: assessment at a transplant centre

A transplant-centre assessment for aplastic anaemia is a discussion about a particular person’s bone marrow failure, current treatment and possible next steps. It should not begin with an assumption that every patient needs transplantation or that a donor found in the family is automatically suitable.

Establish the diagnosis and the question for the centre

Aplastic anaemia affects the marrow’s ability to make enough blood cells. NHLBI describes several treatment approaches, including medicines, transfusion support and blood-forming stem cell transplantation in selected people. The appropriate comparison depends on the clinical assessment. Ask the current haematologist to state the diagnosis, its assessed severity and the reason for referral in a short letter.

Useful referral questions differ: Is transplantation being considered as an initial strategy? Has response to an existing treatment been insufficient? Is the diagnosis itself uncertain? Naming the question prevents a broad “transplant package” from replacing a specialist assessment.

Present the treatment course clearly

  • Provide the marrow report and any investigations used to establish or refine the diagnosis.
  • Attach dated blood counts so the team can see the pattern rather than one isolated result.
  • List previous and current treatments, their start dates and the documented response.
  • Record transfusion dates, significant reactions and any information issued by the blood bank.
  • Include recent infection assessments, admissions and current medicines.

If inherited marrow failure or another diagnosis has been considered, include that correspondence. Do not relabel the condition on your own. The receiving specialist should know which possibilities have been evaluated and which remain unresolved.

Ask how transplant and non-transplant routes are compared

Request an explanation of the expected purpose, main uncertainties and monitoring requirements of each clinically relevant route. Ask what additional assessment is needed before a recommendation becomes final. If a related donor is being considered, clarify who evaluates the donor independently and how suitability will be confirmed. Family willingness is valuable, but it is not a medical clearance.

Donor work, patient assessment and the decision to proceed are separate steps. Ask whether they can run alongside necessary current care and which decisions must wait for results. Do not stop prescribed medicines or transfusion appointments while arranging the review.

Plan support before any international transfer

Discuss whether travel to Turkey is medically appropriate at the proposed time. The current team should identify the required support until handover, and the receiving team should confirm acceptance and its first assessment. An airport transfer or hotel reservation does not establish that medical support is ready.

For a meaningful estimate, separate assessment, donor-related costs if relevant, admission, medicines and follow-up. Ask what happens financially if the assessment recommends a different approach or postponement. Keep a copy of the proposed plan for the local haematologist.

Fever, significant bleeding or rapid deterioration require prompt contact with the treating team and appropriate local care. This article explains how to prepare a referral; it does not decide eligibility for transplantation or replace the existing care plan.

A practical next step

For the practical arrangements, see What to check in a bone marrow transplant cost estimate.

Sources

Medicina Turkey patient information. General guidance; individual medical decisions should be discussed with the treating clinician.